| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $12.9M | +42.1% |
| SG&A Expense | $4.6M | -3.5% |
| Operating Income | -$17.5M | -26.3% |
| Pre-tax Income | -$17.5M | -25.9% |
| Income Tax | $2K | +25.0% |
| Net Income | -$17.5M | -25.9% |
| EPS (Basic) | -$0.78 | +39.1% |
| EPS (Diluted) | -$0.78 | +39.1% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | +143.0% |
| Accounts Receivable | $142K | — |
| Current Assets | $9.7M | +139.7% |
| Total Assets | $13.8M | +90.6% |
| Current Liabilities | $1.5M | +48.6% |
| Total Liabilities | $2.3M | +4.7% |
| Stockholders' Equity | $11.5M | +127.2% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.0M | -26.7% |
| Capital Expenditures | $1.7M | +3.8% |
| Investing Cash Flow | -$1.7M | -3.8% |
| Financing Cash Flow | $21.1M | +186.0% |
| Free Cash Flow | -$15.7M | -23.7% |